Close Menu

NEW YORK (360Dx) — SQI Diagnostics announced today that it has partnered with Toronto-based University Health Network to create a rapid, multiplex test and companion point-of-care device for identifying lung transplant candidates.

Under the terms of the deal, Toronto-based SQI will work with scientists at UHN's Toronto Lung Transplant Program to develop the products. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

Sponsored by

This webinar will provide a first-hand look at how a hematology/oncology lab in the UK set up and validated three molecular assays for routine in-house use.


This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.